AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Q3 2006 Takeda Chemical Industries Earnings Conference Call - Final.

Fair Disclosure Wire

| January 31, 2006 | COPYRIGHT 2006 CQ Transcriptions. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

Original Source: FD (FAIR DISCLOSURE) WIRE

OPERATOR: Thank you for waiting. We will now begin teleconference. Please note that this telephone conference contains certain forward-looking statements and other projected results, which involve known and unknown risks, delays, uncertainties and other factors not under the Company's control, which may cause actual results, performance or achievements of the Company to be materially different from the results, performance or other expectations implied by these projections.

Such factors include economic and market conditions, political events and investor sentiments, liquidity of secondary markets, level and volatility of interest rates, currency exchange rates, security valuations, competitive conditions and size, number and timing of transactions.

During the presentation from the Company, all the telephone lines are placed for listening mode only, and a questions-and-answer session will be held after the presentation. This conference call is being broadcasted through Internet online, but only for listening mode.

Now we start the conference with a presentation.

HIROFUMI INOUE, IR, TAKEDA PHARMACEUTICAL COMPANY LIMITED: (technical difficulty) Conference call of third-quarter financial results for fiscal year ending March 2006 of Takeda Pharmaceutical Company Limited. My name is Hirofumi Inoue, Senior Manager, Public Relations, Investor Relations of Corporate Communications Department of Takeda.

Please let me introduce today's participants from Takeda -- Mr. Hiroshi Takahara, General Manager of Finance and the Accounting Department; Mr. Kazuaki Ikeya, General Manager of Strategic Product Planning Department; Mr. Yasuhiko Yamanaka, General Manager of Corporate Strategy and Planning Department.

Related articles from newspapers, magazines, journals, and more
Takeda Pharmaceutical fails to declare 122.3 bil. yen in income.
Newspaper article from: Kyodo News International (Tokyo, Japan) June 28, 2006 700+ words
Jun. 28--OSAKA -- Takeda Pharmaceutical Co. said Wednesday it failed to declare 122.3 billion yen in taxable income over six years to March...Authorities imposed back taxes worth 57 billion yen under a transfer taxation system but Takeda...
Takeda Pharmaceutical objects order to pay 57 bil. yen in back taxes.
Newspaper article from: Kyodo News International (Tokyo, Japan) August 25, 2006 700+ words
Aug. 25--OSAKA -- Takeda Pharmaceutical Co. said Friday it filed an objection...Bureau's order to pay 57 billion yen in back taxes in connection with its...failed to declare 122.3 billion yen in taxable income in six years to...
Takeda Pharmaceutical Company renews record first-half sales, net profit.
Newspaper article from: Kyodo News International (Tokyo, Japan) November 5, 2004 700+ words
Nov. 5--TOKYO -- Takeda Pharmaceutical Co. said Friday its consolidated...earlier to 163.24 billion yen in the six months through September...record of 140.55 billion yen set in the first half of the...per share came to 184.40 yen, compared with 158.76 yen...
Takeda Pharmaceutical sees record 1st-half group net profit, sales.
Newspaper article from: Kyodo News International (Tokyo, Japan) November 4, 2005 700+ words
Nov. 4--TOKYO -- Takeda Pharmaceutical Co. saw all-time highs in...year ago to 181.27 billion yen on sales of 599.84 billion yen, up 5.8 percent. Group...percent to 259.43 billion yen. Net profit per share came...
Takeda Pharmaceutical sees 1st profit fall in 11 years.
Newspaper article from: Kyodo News International (Tokyo, Japan) May 11, 2005 700+ words
May 11--TOKYO -- Takeda Pharmaceutical Co. said Wednesday it posted...percent to 442.11 billion yen. But operating profit rose 3.7 percent to 385.28 billion yen on a 3.4 percent increase...overall sales to 1.12 trillion yen. Group net profit per share...
Takeda Pharmaceutical posts record sales for 16th year, profit up.(Financial...
Newspaper article from: Kyodo News International (Tokyo, Japan) May 10, 2007 700+ words
May 10--TOKYO -- Takeda Pharmaceutical Co. said Thursday its group...percent to 335.81 billion yen in fiscal 2006, with solid...percent to 585.02 billion yen on a 7.7 percent sales rise to 1.31 trillion yen. The company attributed...
TAKEDA PHARMACEUTICAL TO RAISE PAYOUT RATIO TO 30% FOR FY05.
News wire article from: AsiaPulse News November 9, 2004 700+ words
...TOKYO, Nov 9 Asia Pulse - Takeda Pharmaceutical Co. (TSE:4502) plans...per-share dividend to 88 yen for the current fiscal year, up 3 yen from the previous projection...which stood at 1.4 trillion yen (US$13.3 billion) on...
Takeda Pharmaceutical to sell food business to House in '07.
Newspaper article from: Kyodo News International (Tokyo, Japan) December 26, 2005 700+ words
Dec. 26--OSAKA -- Takeda Pharmaceutical Co. will sell its food business...for an estimated 30 billion yen, the two companies said Monday...sharply from about 10 billion yen at present. Takeda Food...segment stood at 37.5 billion yen in the previous fiscal year...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA